The oxygen transport capacity of phospholipid vesicles encapsulating purified Hb (HbV) produced with a PO2 at which Hb is 50% saturated (P50) of 8 (HbV8) and 29 mmHg (HbV29) was investigated in the hamster chamber window model by using microvascular measurements to determine oxygen delivery during extreme hemodilution. Two isovolemic hemodilution steps were performed with 5% recombinant albumin (rHSA) until Hct was 35% of baseline. Isovolemic exchange was continued using HbV suspended in rHSA solution to a total [Hb] of 5.7 g/dl in blood. P50 was modified by coencapsulating pyridoxal 5Ј-phosphate. Final Hct was 11% for the HbV groups, with a plasma [Hb] of 2.1 Ϯ 0.1 g/dl after exchange with HbV8 or HbV29. A reference group was hemodiluted to Hct 11% with only rHSA. All groups showed stable blood pressure and heart rate. Arterial oxygen tensions were significantly higher than baseline for the HbV groups and the rHSA group and significantly lower for the HbV groups compared with the rHSA group. Blood pressure was significantly higher for the HbV 8 group compared with the HbV29 group. Arteriolar and venular blood flows were significantly higher than baseline for the HbV groups. Microvascular oxygen delivery and extraction were similar for the HbV groups but lower for the rHSA group (P Ͻ 0.05). Venular and tissue PO 2 were statistically higher for the HbV 8 vs. the HbV29 and rHSA groups (P Ͻ 0.05). Improved tissue PO2 is obtained when red blood cells deliver oxygen in combination with a high-rather than low-affinity oxygen carrier. oxygen-carrying capacity; blood substitutes; tissue oxygen; hemoglobin oxygen affinity PHOSPHOLIPID VESICLES encapsulating concentrated hemoglobin (Hb) solution [Hb vesicles (HbV) or liposome-encapsulated Hb] provide oxygen-carrying capacity to plasma expanders, reproducing several of the characteristics of red blood cells (RBC) suspended in plasma. HbV contain Hb at a high concentration within a cell membrane-like structure. Their oxygen dissociation curve can be adjusted by varying the concentration of pyridoxal 5Ј-phosphate (PLP). A widely accepted premise for designing a blood substitute is that its Hb should have an oxygen dissociation curve like that of RBC or one that is right shifted, i.e., having a high P 50 to facilitate the unloading of oxygen (P 50 is the partial pressure of oxygen at which the Hb molecule is 50% saturated). In a previous study by Sakai et al. (16), vesicles were formulated with P 50 values set at 9, 16, and 30 mmHg. The study showed that optimal tissue oxygen conditions were obtained when 80% of the circulating blood was substituted with HbV whose P 50 was 16 mmHg, a value considerably lower than the usual value of 28 mmHg for normal blood (16). Oxygen-carrying capacity was found to be well above the oxygen supply limitation.
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Recent developments in the field of oxygen-carrying plasma expanders (OCPE) based on molecular Hb solutions reported by Tsai et al. (22) show that the addition of comparatively small amounts of a significantly left-shifted polyethylene glycol-conjugated oxygen carrier (P 50 ϳ5 mmHg) to blood in extreme hemodilution leads to baseline microvascular and systemic conditions. This result could not be obtained in identical extreme hemodilution experiments with the use of a right-shifted molecular Hb solution at a considerably higher concentration (19) .
Extreme hemodilution in the hamster window chamber model to a hematocrit (Hct) level of ϳ11% is a powerful tool to test the efficacy of OCPEs in restoring microvascular function and systemic conditions. This Hct is below the threshold at which the organism becomes oxygen supply limited (5, 22, 23) . In this scenario, the effects of a blood substitute became magnified upon introduction into the circulation. Furthermore, by encapsulating Hb, a phospholipid vesicle eliminates the problem of Hb extravasation and provides a setting in which the biophysical properties of the infusion solution can be rigorously controlled while allowing for the change in P 50 . Therefore, experimenting with vesicles that encapsulate Hb formulated with different P 50 values provides the unique opportunity to investigate how oxygen affinity regulates oxygen delivery to the tissue by the microcirculation, a value not attainable by lowering RBC Hb P 50 by the administration of sodium cyanate, which may introduce changes in tissue metabolism (7) . In addition, RBC and HbV are different in size, flow pattern, homogeneous distribution in the plasma phase, and the mechanism of oxygen unloading in capillaries, and direct comparison between RBC and HbV is impossible. All these conditions indicate that the optimal P 50 should be different in HbV and RBC.
In the present study, we investigated the microvascular effects of restoring oxygen-carrying capacity in conditions of extreme hemodilution, introducing by exchange transfusion identical amounts of Hb-carrying vesicles in which oxygen affinity was specifically controlled so that P 50 was either 8 or 29 mmHg. The P 50 value of 8 mmHg was chosen because it is similar to that of a recently developed oxygen carrier that is effective at a low concentration (2) (3) (4) 22) . In these experiments, the hemodilution protocols were performed using a recombinant albumin solution (13) as the plasma expander.
METHODS
Investigations were performed in male golden Syrian hamsters (55-65 g body wt) fitted with a dorsal skinfold chamber window (6) . This model has been used extensively for investigations of the intact microvasculature of adipose and subcutaneous tissue and skeletal muscle in conscious animals for extended periods. Pentobarbital sodium (50 mg/kg ip) was used for window implantation and for carotid artery and jugular vein catheterization. The microvasculature was examined 4 -5 days after the initial surgery, and only animals passing an established systemic and microcirculatory inclusion criteria, which included having tissue void of low perfusion, inflammation, and edema (21) , were entered into the study. Animal handling and care followed the NIH Guide for the Care and Use of Laboratory Animals. The experimental protocol was approved by the local animal care committee.
Preparation of HbV with different P 50. HbV were prepared under sterile conditions as previously reported (12, 15) . Hb was purified from outdated donated blood provided by the Hokkaido Red Cross Blood Center (Sapporo, Japan) and the Japanese Red Cross Society (Tokyo, Japan). The encapsulated purified Hb (38 g/dl) contained 0 or 14.7 mM PLP (Sigma Chemical, St. Louis, MO) as an allosteric effector at a molar ratio of [PLP]/[Hb] ϭ 0 or 2.5, respectively. The lipid bilayer was composed of a mixture of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine, cholesterol, and 1,5-bis-O-hexadecyl-Nsuccinyl-L-glutamate at a molar ratio of 5:5:1 (Nippon Fine Chemical, Osaka, Japan) and 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-poly(ethylene glycol) (0.3 mol% of the total lipid; NOF, Tokyo, Japan) (17) . HbV with a 250-nm diameter were suspended in a physiological saline solution in which [Hb] ϭ 10 g/dl, sterilized with filters (Dismic, pore size 0.45 m; Toyo Roshi, Tokyo, Japan), and deoxygenated with N 2 bubbling for storage (14) . The content of lipopolysaccharide was Ͻ0.1 EU/ml. Before use, the HbV suspension ([Hb] ϭ 10 g/dl, 8.6 ml) was mixed with a solution of recombinant human serum albumin (rHSA 25%, 1.4 ml; Nipro, Osaka, Japan) to regulate the rHSA concentration in the suspending medium of the vesicles to 5 g/dl. Under this condition, the colloid osmotic pressure of the suspension is ϳ20 mmHg (Wescor 4420 colloid osmometer; Wescor, Logan, UT) (12) . As a result, the Hb concentration of the suspension was 8.6 g/dl.
In a previous study (16) , HbV were suspended in 8 g/dl HSA. However, we changed to 5 g/dl rHSA because it showed better microvascular perfusion in the hamster window model (i.e., increased red cell velocity and functional capillary density) than 8 g/dl HSA. The suspension was filtered through sterile filters (pore size 0.45 m; Millipore, Billerica, MA). The characteristics of HbV are listed in Table 1 , with all parameters being almost identical except oxygen affinity (HbV 8, P50 ϭ 8 mmHg; HbV29, P50 ϭ 29 mmHg).
Measurements of P50 and rate of oxygen release from HbV. The P50 and Hill number of each HbV and Hb solution were calculated from oxygen dissociation curves measured with a Hemox analyzer (TCS-Medical Products) at 37°C ( Fig. 1) .
Acute isovolemic exchange-transfusion (hemodilution) protocol. Progressive hemodilution to a final systemic Hct level of 11% was accomplished with three isovolemic exchange steps. This protocol, leading to extreme hemodilution while maintaining stable hemodynamic conditions, is described in detail in a previous report by Tsai (19) . Briefly, the volume of each exchange-transfusion step was calculated as a percentage of the blood volume, estimated as 7% of the body weight. An acute anemic state was induced by lowering systemic Hct by 60% with two steps of progressive isovolemic hemodilution using 5% rHSA, referred to as exchange levels 1 and 2. Level 1 exchange was 40% of blood volume, and level 2 and 3 exchanges were 35% of blood volume, respectively.
After level 2, the animals were randomly divided into three experimental groups by being assigned to an experimental group according to a sorting scheme based on a list of random numbers (1). Level 2 exchange was followed by level 3 exchange. Hemodilution with 5% rHSA solution was continued with one group of the level 2 hemodiluted animals, the experimental group rHSA, until Hct was decreased to 11% of baseline (Fig. 2) . The test materials were studied by assigning the remainder of the level 2 animals to groups labeled HbV 8 (P 50 ϭ 8 mmHg) and HbV29 (P50 ϭ 29 mmHg) and were hemodiluted using these materials, reducing Hct to 11%. Plasma Hb concentrations derived for HbV8 and HbV29 after exchange of 35% blood volume are estimated around 2.0 -2.3 g/dl for both groups (35% of estimated total Hb content) (21) .
Because mixed blood is withdrawn during the exchanges, a 110% blood volume exchange was needed to reduce Hct to 25% of baseline (11% Hct). Test solutions were infused into the jugular vein catheter after passing through an in-line, 13-mm-diameter, 0.2-m syringe filter at a rate of 100 l/min. Blood was simultaneously withdrawn using a dual syringe pump ("33" syringe pump; Harvard Apparatus, Holliston, MA) at the same (isovolemic-normovolemic) rate from the carotid artery catheter (4, 5, 19) . This slow rate of exchange provided for a stable mean arterial pressure immediately after the exchange. Each animal was allowed a 10-min stabilization period before data acquisition.
Blood chemistry and biophysical properties. Arterial blood was collected in heparinized glass capillaries (0.05 ml) and immediately Viscosity was measured at a shear rate of 160 s Ϫ1 at 37°C. COP, colloid osmotic pressure measured at 27°C; P50; partial pressure of oxygen at which Hb is 50% saturated; rHSA, recombinant human serum albumin; HbV8 and HbV29, Hb vesicles with a P50 of 8 and 29 mmHg, respectively. analyzed for arterial PO2 (PaO 2 ), arterial PCO2 (PaCO 2 ), base excess (BE), and pH (Blood Chemistry Analyzer 248; Bayer, Norwood, MA). The comparatively low Pa O 2 and high PaCO 2 values of these animals is a consequence of their adaptation to a fossorial environment. Blood samples for viscosity and colloid osmotic pressure measurements were quickly withdrawn from the animal with a heparinized 5-ml syringe at the end of the experiment for immediate analysis.
Viscosity was measured in a cone/plate viscometer (DV-IIϩ) with a cone spindle (CPE-40; both from Brookfield Engineering Laboratories, Middleboro, MA) at a shear rate of 160 s Ϫ1 . Colloid osmotic pressure (COP) was measured using the Wescor 4420 colloid osmometer (23) .
Functional capillary density. Functional capillary density (FCD; in cm Ϫ1 ) is the total length of RBC-perfused capillaries divided by the area of the microscopic field of view (21) . Capillary segments were considered functional if RBC were observed to transit over a 30-s period. FCD was tabulated from the capillary lengths with RBC flow in an area comprising 10 successive microscopic fields (420 ϫ 320 m). Detailed mappings were made of the chamber vasculature to study the same microvessels throughout the experiment.
Microhemodynamic parameters. Arteriolar and venular blood flow velocities were measured online using the photodiode cross-correlation technique (8) (Fiber Optic Photo Diode and Velocity Tracker Correlator model 102B; Vista Electronics, Ramona, CA). The centerline velocity (V) was corrected according to vessel size to obtain the mean RBC velocity (11) . The video image shearing technique was used to measure vessel diameter (D) online. Blood flow was calculated from the measured parameters as (Q) ϭ V(D/2) 2 .
Microvascular PO2 distribution. High-resolution microvascular PO2 measurements were made using phosphorescence-quenching microscopy (18), a method based on the oxygen-dependent quenching of phosphorescence emitted by albumin-bound metalloporphyrin complex after pulsed light excitation. Phosphorescence microscopy is not dependent on the level of dye within the tissue, and the decay time is inversely proportional to the PO 2 level. The phosphorescence decay curves were converted to oxygen tensions by using a fluorescence decay curve fitter (model 802; Vista Electronics) (9) . This technique has been used in this animal preparation and others for both intravascular and extravascular oxygen tension measurements, because albumin exchange between plasma and tissue allows for sufficient concentrations of albumin-bound dye within the interstitium to achieve an adequate signal-to-noise ratio. Animals received a slow intravenous injection of 15 mg/kg body wt at a concentration of 10.1 mg/ml of a palladium-meso-tetra(4-carboxyphenyl)porphyrin (Porphyrin Products, Logan, UT). PO 2 measurements were made 20 min after porphyrin injection, allowing it to be distributed to all the tissues.
In our system, intravascular measurements are made by placing an optical rectangular window (5 ϫ 40 m) within the vessel of interest, with the longest side of the rectangular slit positioned parallel to the vessel wall. Tissue PO2 is measured in regions void of large vessels within intercapillary spaces with an optical window size of ϳ10 ϫ 10 m, which allows us to precisely establish the localization of the PO 2 measurements in arterioles, venules, and the interstitium (20) . The phosphorescence decay due to quenching at a specific PO 2 yields a single decay constant, and in vitro calibration has been demonstrated to be valid for in vivo measurements. Intravascular and perivascular PO 2 measurements were made in the arterioles studied, and intravascular PO2 measurements were made in venules. Interstitial tissue PO2 was measured in regions distant from visible underlying and adjacent vessels.
Tissue oxygen delivery and extraction. The microvascular methodology used in our studies allows a detailed analysis of oxygen supply in the tissue. Calculations of O 2 delivery, defined as the amount of oxygen delivered by the arterioles to the microcirculation per unit time normalized relative to baseline, and O 2 extraction, defined as the amount of oxygen released by blood to the tissue by the microcirculation per unit time normalized relative to baseline, were made using Eqs. 1 and 2:
where RBCHb is the [Hb] in RBC (expressed in g/dl of blood), HbVHb is the [Hb] in HbV (expressed in g/dl of blood), ␥ is the oxygencarrying capacity of Hb at 100% saturation (or 1.34 ml O2/g Hb), Sa% indicates the arteriolar oxygen saturation of RBC or HbV, S(a-v)% indicates the arteriovenous difference in oxygen saturation of RBC or HbV, (1 Ϫ Hct) is the fractional plasma volume (and converts the equation from units per dl of plasma to per dl of blood), ␣ is the solubility of oxygen in plasma and is equal to 3.14 ϫ 10 Ϫ3 ml O2/dl plasma mmHg, PaO 2 is the arteriolar partial pressure of oxygen, P(a-v)O2 is the arteriovenous difference in PO2, and Q is the microvascular flow for each microvessel as a percentage of baseline. The oxygen dissociation curves were determined as described before. In this analysis, microvascular Hct was corrected according to the findings of Lipowsky and Firrell (10) . Experimental procedure. Baseline systemic, microvascular, and hemodynamic characterizations were performed before the start of the exchange. After each exchange and a stabilization period of 10 min, systemic and/or microvascular measurements were performed. Exchanges began every hour. After the level 3 exchange transfusion, the same measurements were repeated, and then the PO 2 distribution was determined using phosphorescence-quenching microscopy (9) . The duration of the experiment was 3-4 h. Fig. 2 . Hemodilution was attained by means of a progressive, stepwise, isovolemic blood exchange-transfusion protocol. Volume of each exchange-transfusion step was calculated as a percentage of the blood volume, estimated as 7% of body weight. An acute anemic state was induced by lowering systemic Hct, using a 5% recombinant human serum albumin (rHSA) solution, in 2 progressive steps of isovolemic hemodilution labeled level 1 and level 2 exchanges. Level 3 exchange was achieved by a third hemodilution that continued using rHSA or the vesicle solutions HbV8 or HbV29 suspended in 5% rHSA (test solutions). RBC, red blood cells.
Data analysis. Results are presented as means Ϯ SD unless otherwise noted. All data are presented as absolute values and ratios relative to baseline values. A ratio of 1.0 signifies no change from baseline, whereas lower and higher ratios are indicative of changes proportionally higher or lower than baseline. The same vessels and functional capillary fields were followed so that direct comparisons to their baseline levels could be performed, allowing for more robust statistics for small sample populations. For repeated measurements, time-related changes were assessed by analysis of variance (ANOVA). Data within each group were analyzed using ANOVA for nonparametric repeated measurement, and when appropriate, post hoc analyses were performed with the Dunn's multiple comparison tests. For level 3 exchange, groups were analyzed using one-way ANOVA, and post hoc analyses were performed with the Bonferroni post tests. All statistics were calculated using GraphPad Prism 4.01 (GraphPad Software, San Diego, CA). Changes were considered statistically significant if P Ͻ 0.05.
RESULTS

Exchange transfusion.
Twenty-four animals (55-65 g body wt) entered into the exchange-transfusion (hemodilution) protocol, and all tolerated the experiment without any visible discomfort. Microvascular studies were completed in six preparations for each test material, namely, the level 2 rHSA, HbV 8 , and HbV 29 . The data were analyzed using a model for computing oxygen delivery to the tissue at the microscopic level.
Hematological changes. The exchange-transfusion protocol resulted in a final Hct ranging from 11.0 Ϯ 0.5 to 11.4 Ϯ 0.6%. The HbV 8 and HbV 29 groups had a final plasma Hb concentration of 2.1 Ϯ 0.1 g/dl, which increased the total Hb concentration in blood (RBC ϩ Hb in plasma) to 5.7 Ϯ 0.2-0.3 g/dl after completion of the level 3 exchange transfusion. Thus oxygen-carrying capacities at this level were similar to those found at level 2, where total blood Hb concentration was 5.7 Ϯ 0.3 g/dl (Hct 18.1 Ϯ 0.7) ( Table 2) .
Systemic and blood gas parameters. Changes in the systemic parameters are presented in Fig. 3 . Mean arterial pressure was statistically lower for the extreme hemodilution tests with rHSA and the HbV 29 group and attained the highest value with HbV 8 viscosity. Heart rate after hemodilution followed by exchange transfusion with the HbV solutions was ϳ10% higher than baseline at the level 3 exchange. The slight increase in heart rate was not statistically different. (Table 2 ) showed a statistical increase in PO 2 after hemodilution and exchange transfusion. Pa CO 2 was unchanged from baseline after hemodilution. Blood pH was not statistically changed. At level 3 exchange, BE was positive and not statistically different between HbV groups, but it was negative and statistically different from baseline for the rHSA group (P Ͻ 0.05).
Analysis of arterial blood gases
Colligative properties. Blood viscosities and COP after level 3 exchange were sampled at 1 h and 10 min after completion Values are means Ϯ SD. Baseline values include all animals in the study. No significant differences were detected between the baseline values of each group or between the values after level 1 and level 2 exchange before the exchange with test solutions. Hct, systemic hematocrit; Hb, hemoglobin content of blood; Pao 2 , arterial partial O2 pressure; PaCO 2 , arterial partial pressure of CO2; BE, base excess. *P Ͻ 0.05 compared with baseline; †P Ͻ 0.05 compared with level 3 rHSA; ‡P Ͻ 0.05 compared with level 3 HbV8 to level 3 HbV29. of the exchange. Table 3 shows that blood viscosity ranges from 1.6 cp (plasma 0.9 cp) for rHSA to 2.0 cP (plasma 1.0 cp) for the HbV groups.
All test materials caused COP to maintain the value for normal blood for this species (5) , namely, 17.6 Ϯ 0.7 mmHg at 1 h after the last exchange, showing that introduction of bulk solutions into the circulation caused minor fluid shifts.
Microhemodynamics. After level 3 exchange, arteriolar and venular diameters were not statistically different from baseline for any of the groups. Arteriolar flow velocities attained the highest value for the HbV 8 group, being 1.90 relative to baseline, which was statistically significant. The same effect was found in the venular microcirculation, where blood flow velocity was 2.20 relative to baseline. HbV 29 exchange transfusion lowered both arteriolar and venular velocities relative to the values attained at the level 2 exchange. However, venular velocity in this group was statistically significantly higher than in baseline. Notably, the level 2 hemodilution with rHSA caused significantly higher blood flow velocities in the arteriolar and venular microcirculation (Fig. 4) .
Combining data for the RBC flow velocity and diameter allowed calculation of the arteriolar and venular blood flows (Fig. 5 ). The results of this calculation showed that all exchanges caused blood flow to increase. Arteriolar and venular blood flows at level 2 exchange with the use of rHSA were significantly higher than those at baseline. However, continuing hemodilution with this material to level 3 exchange did not sustain the increase, and arteriolar and venular blood flow, although showing a tendency to remain elevated, were not statistically different from baseline values.
Level 3 exchange transfusion with HbV 8 and HbV 29 caused blood flow to be significantly higher than baseline. Furthermore, the HbV 8 group showed consistently higher blood flows than the HbV 29 group; however, the trend was not statistically significant.
Functional capillary density. The number of capillaries with RBC passage upon level 3 hemodilution in the rHSA, HbV 8 , and HbV 29 groups was 62 Ϯ 9, 76 Ϯ 12, and 72 Ϯ 13% of baseline, respectively. These values were statistically different from baseline but not statistically different with respect to each other (Fig. 6) .
Microvascular oxygen distribution. Oxygen tension measured using phosphorescence microscopy after level 3 exchange transfusion in the rHSA, HbV 8 , and HbV 29 groups showed that these materials produced virtually identical distributions of arteriolar microvascular PO 2 (arterioles averaged 49.5 mmHg), although HbV 8 tended to be higher (Fig. 7) . The decrease of RBC from level 2 to level 3 did not decrease the arteriolar PO 2 . Venular PO 2 after level 3 was significantly lower than at level 2 exchange in all cases (rHSA, 7.2 Ϯ 3.2 mmHg; HbV 8 , 15.1 Ϯ 3.7 mmHg; HbV 29 , 9.6 Ϯ 4.2 mmHg).
Tissue PO 2 values at level 3 exchange were consistently lower than those at level 2 exchange (20.1 Ϯ 2.2 mmHg), with the difference being statistically significant. The highest was attained by the HbV 8 group, being 14.0 Ϯ 2.2 mmHg. By comparison, tissue PO 2 for the HbV 29 group was 9.2 Ϯ 2.7 mmHg and for the rHSA group, 2.6 Ϯ 1.4 mmHg, which was significantly lower compared with the HbV 8 and HbV 29 groups (Fig. 7) .
Oxygen delivery and extraction. Figure 8 shows the results of the analysis for delivery and release of oxygen by the Values are means Ϯ SD; n ϭ no. of animals studied. Viscosity was measured at a shear rate of 160 s Ϫ1 at 37°C. COP was measured at 27°C. Hct are presented in Table 2 . *P Ͻ 0.05 compared with nondiluted blood. microcirculation. It is apparent that exchanging RBC for HbV 8 maintains oxygen delivery to the tissue, whereas HbV 29 reduces this by ϳ20%, and continued hemodilution with a non-oxygen-carrying material significantly depresses oxygen delivery to the tissue, reducing this to half of that attained at the level 2 hemodilution.
DISCUSSION
The principal finding of this study is that under identical extreme hemodilution conditions, with the use of vesicles encapsulating Hb with normal P 50 (HbV 29 ϭ 29 mmHg) and low P 50 (HbV 8 ϭ 8 mmHg), tissue PO 2 is statistically significantly higher when the high oxygen affinity material is used, namely, 14.0 Ϯ 2.2 vs. 9.2 Ϯ 2.7 mmHg. The significantly increased tissue PO 2 attained with HbV 8 appears to be due to a series of incremental improvements in microvascular and macrovascular hemodynamics comprising the increase of arteriolar blood flow and mean arterial blood pressure, which was significantly higher (P Ͻ 0.05) for HbV 8 than for HbV 29 .
In the hemodilution procedures of this study, blood was exchanged with a rHSA solution as a colloidal plasma expander, which was the same suspending medium used for the Hb vesicles. Therefore, in these experiments, we can make a direct comparison between an oxygen-carrying and non-oxy-gen-carrying blood substitute, uncomplicated by the presence of additional materials. Our results show that the level 2 hemodilution with rHSA leads to maintained functional capillary density and significantly improved arteriolar and venular blood flow, although somewhat lowered central blood pressure. The latter finding is not necessarily negative and may reflect a lowered overall peripheral vascular resistance due to the decrease of blood viscosity after hemodilution. The fact that microvascular flow is significantly increased indicates that the level 2 hemodilution with rHSA provides the tissue with adequate microvascular perfusion and that this colloid is an adequate plasma expander.
Average oxygen delivery and extraction were somewhat greater for HbV 8 than for HbV 29 . These are calculated values and are not statistically significantly different; however, the same difference was found in all micro and macro parameters measured in this study.
The level 2 hemodilution and the succeeding level 3 hemodilution with either HbV 8 and HbV 29 resulted in the same total Hb concentration in the circulation (5.7 and 5.8 g Hb/dl); however, oxygen delivery was lower with HbV 29 and lowest with rHSA, as might be expected due to the low Hb content (3.7 g Hb/dl) in the absence of plasma Hb for the rHSA group. Therefore, because all groups had the same Hct at the level 3 hemodilution, the sustained oxygen consumption and tissue PO 2 relative to the rHSA group clearly demonstrate that Hb vesicles release oxygen. However, the vesicles with the lowest P 50 provide an oxygen delivery capacity identical to that of blood at level 2 hemodilution, whereas vesicles with a high P 50 lower oxygen delivery at the microcirculatory level, an effect probably caused by the decreased blood flow associated with HbV 29 .
The differences in tissue PO 2 , mean arterial blood pressure, and arteriolar blood flow between HbV 8 and HbV 29 show that in designing a blood substitute, it is not sufficient to provide adequate oxygen-carrying capacity. Once a suitable oxygen carrier is available, it also must be able to maintain or enhance other circulatory transport parameters, particularly flow. The Hb vesicles used in this study are vasoinactive, and the difference in P 50 appears to be a factor in improving flow condition that is not related to vasoactivity. An explanation for this may be related to the inherent variability of tissue PO 2 shown in this and other studies (4, 22) , which may be enhanced in extreme hemodilution. This variability determines that if average tissue PO 2 is low, portions of the tissue may become anoxic. Introducing a small quantity of a low-P 50 Hb oxygen carrier into the circulation will deliver oxygen only to those parts of the tissue where the anoxic threshold is passed, thus eliminating the inherent variability of oxygen delivery shown by the variability of tissue PO 2 .
Considering the significantly improved blood pressure and the trend toward higher flow for HbV 8 (in the absence of vasoconstriction and changes in the rheological properties of blood), it is possible that in conditions of extreme hemodilution the cardiac function should be improved because of the proposed more homogenous heart tissue oxygenation using HbV 8 vs. HbV 29 .
In summary, the present results show that either HbV 8 or HbV 29 are efficient oxygen carriers that do not cause vasoactivity. The experiments were carried out using rHSA as a hemodiluent, and this material was adequate as a plasma volume substitute. Oxygen extraction was similar for both oxygen carriers; however, HbV 8 appeared to be beneficial at the systemic level, because base excess remained at baseline levels, whereas it was decreased for HbV 29 . This finding suggests that improved tissue PO 2 and microcirculatory oxygen delivery may be efficient in other tissues. The improvement obtained may be specific to the conditions of these experiments in which the vesicles were tested for their capacity to restore tissue PO 2 , FCD, and oxygen extraction in the microcirculation during extreme hemodilution. The significant differences in the tissue oxygen parameters produced by the presence of low-P 50 Hbs vs. an identical oxygen carrier with normal P 50 suggests that small amounts of Hbs with high oxygen affinity may have therapeutic effects in the treatment of ischemic conditions (6). Fig. 8 . Arterial oxygen delivery (DO2) and extraction (VO2) before and after the level 3 hemodilution. Calculations of global oxygen transport are not directly measurable in our model; however, the changes relative to baseline can be calculated using the measured parameters. These calculations can be identified as those presented without standard deviations to focus on their tendencies rather than on the variability of the measurement.
